Skip to main content
. 2020 Sep 14;10(9):691. doi: 10.3390/diagnostics10090691

Table 5.

Pathogen diagnostics in patients with schizophrenia spectrum disorders (SSDs). Values with alterations in >10% are marked in bold. * Activity parameters were negative. Lues-TPPA-positive, Lues-FTA-Abs immunoglobin (Ig)M negative, Lues-FTA-Abs IgG-positive, Lues cardiolipin agglutination-negative.

Patients with SSDs (N = 76)
Serology for Lyme disease
IgM-ELISA screening (ref. up to 5 units) 3↑ (4%), 64 normal (89%), 5 borderline (7%) (N = 72)
IgG-ELISA screening (ref. up to 16 RE) 10↑ (14%), 60 normal (83%), 2 borderline (3%) (N = 72)
Western blot confirmation test (only performed if ELISA screening was conspicuous) 5 positive (7%), 14 negative (N = 19)
-- IgM: negative: 8, positive: 0
-- IgG: negative: 7, positive: 5
Serology for lues
Screening using CLIA (ref. < 0.9) 1 *↑ (1%), 72 normal (99%) (N = 73)